Surolan (miconazole nitrate, polymyxin B sulfate, prednisolone acetate)

Surolan® (miconazole nitrate, polymyxin B sulfate, prednisolone acetate) for dogs

Featuring a unique combination of three effective ingredients backed by 30 years of trust, Surolan provides a well-rounded attack against otitis externa.

Discover a trusted way to get back to healthy ears with Surolan otic suspension. Contact your distributor to order.

Why choose Surolan?

  • Coins with dollar sign displayed
    It's a cost-effective solution

  • Image alt tag 	Mortle and pestle with Rx sign on it
    It provides a distinct combination of active ingredients

  • Image alt tag 	Check marks within a circle
    It is a proven product with 30+ years of clinical experience

Surolan dosing information

Dosage - 5 drops per affected ear
Times/Day -

2x daily

Duration -

7 consecutive days

3 effective ingredients. 30 years of trust.

  • Droplets
    Easy to use

  • Home icon
    Administered at home

  • Image alt tag 	Monthly calendar with 2x highlighting one week
    Twice daily for 7 days

See how Surolan can be a first-line, cost-effective treatment for your patients.

Surolan is available through most distributors. Contact your Elanco sales representative for more info.

SUROLAN® (miconazole nitrate, polymyxin B sulfate, prednisolone acetate) is indicated for the treatment of canine otitis externa associated with susceptible strains of yeast (Malassezia pachydermatis) and bacteria (Staphylococcus pseudintermedius).

Important Safety Information

Do not use Surolan® otic suspension in dogs with known perforated tympanum or with drugs known to induce ototoxicity. If overgrowth of non-susceptible bacteria or fungi occurs, treatment should be discontinued and appropriate therapy instituted. Long-term use of topical otic corticosteroids has been associated with adrenocortical suppression and iatrogenic hypoadrenocorticism in dogs. The safe use of Surolan® in breeding animals has not been evaluated. Please see product insert for full prescribing information.